Contemporary Spine Surgery Series: Motion-sparing Devices - Has the Concept Come of Age?

Dr. Chris Bono addresses motion-sparing devices - past, present and future.

Christopher M. Bono, MD discusses the disjointed rationale - benefits and disadvantages -- of motion sparing technologies. His presentation includes thought-provoking data about devices and diagnosis of particular degenerative spinal conditions.

Release Date: July 22, 2009
Expiration Date: July 22, 2010

Faculty

  • Christopher M. Bono, MD About

    Orthopaedic Surgeon
    Chief of Orthopaedic Spine Service

    Brigham and Women's Hospital
    Boston, MA

    Doctor Christopher Bono is a board-certified orthopaedic surgeon and Chief of Orthopaedic Spine Service at Brigham and Women's Hospital, Department of Orthopaedic Surgery in Boston, MA. Dr. Bono also is Assistant Professor, Orthopaedic Surgery at Harvard Medical School and Co-Director, Harvard MGH-BWH Combined Orthopaedic Spine Fellowship. In addition, he serves as Adjunct Staff in the Spine Research Center, Department of Orthopaedic Surgery at the Medical College of Ohio in Cincinnati, OH.    Read More

Target Audience

The online continuing education program is intended for orthopaedic and neurological surgeons, residents, and fellows who include spinal surgery in their practices.

Educational Objectives

  • Discuss the devices and data: pedicle-based dynamic rods, facet replacement, and interspinous devices.
  • Discuss the diagnosis: discogenic low back pain, degenerative spondylolisthesis, spinal stenosis, and facet syndrome.
  • Describe disjointed rationale of motion-sparing technology along with the benefits, drawbacks, and challenges.

Course Completion Time

Based upon trials, the estimated time to complete this program is 0.5 hour.

Sponsorship

This activity is sponsored by Medical Education Resources, Inc., a non-profit medical education company. BroadWater, a Vertical Health, LLC company, was selected to manage program development logistics.

Educational Grant

This activity received a restricted educational grant from K2M, Inc.

Physician Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medical Education Resources and BroadWater. Medical Education Resources is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Medical Education Resources designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy

It is the policy of Medical Education Resources (MER) to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/ authors participating in our programs are expected to disclose any relationships they may have with commercial companies whose products or services may be mentioned so that participants may evaluate the objectivity of the presentations.

Faculty Disclosure

In accordance with U.S. Food and Drug Administration (FDA) and ACCME guidelines, the financial and significant relationships to this program are listed below.

Christopher M. Bono, MD has indicated the following relevant financial relationships: Synthes Spine, Stryker Spine, Medtronic: Grants/Research Support and DePuy Spine, Medtronic, Stryker Spine, Life Spine®: Consultant

Staff Disclosure

Jeremy Longhurst, Susan Spinasanta: Nothing to disclose.

The staff at MER has nothing to disclose.

Advisor/Staff Disclosures
Jason M. Highsmith, MD: Speakers Bureau: Boston Scientific, Globus Medical

Disclaimer

The content and views presented in this educational activity are those of the faculty and do not necessarily reflect those of Medical Education Resources.

A restricted educational grant in support of this program was provided by: K2M, Inc.

Purpose
This program is for educational and scientific purposes only. Any discussion of a product will be objective, balanced, and scientifically rigorous.

Off-Label/Investigational Use

It should be noted that specific medicines and medical devices discussed or referred to in this program may not yet be specifically cleared by the FDA for use in the United States. It is emphasized that package inserts must be referred to for labeling limitations for products used in the United States.

Software Requirements